|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.110 EUR | +0.91% |
|
-5.13% | -83.43% |
| Nov. 26 | Carmat: share price rises, scientific forum a success | CF |
| Nov. 13 | Carmat: 30 heart transplants passed | CF |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 46.63M 49.02M 43.44M 38.72M 68.96M 4.15B 75.71M 540M 200M 1.7B 184M 180M 7.33B | P/E ratio 2024 * |
-0.94x | P/E ratio 2025 * | -1.23x |
|---|---|---|---|---|---|
| Enterprise value | 96.82M 102M 90.19M 80.39M 143M 8.62B 157M 1.12B 416M 3.54B 382M 374M 15.22B | EV / Sales 2024 * |
9.61x | EV / Sales 2025 * | 6.49x |
| Free-Float |
89.33% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: CARMAT
| CARMAT : Invest Securities lowers its target | Sep. 09 | CF |
| CARMAT : Oddo BHF confirms its recommendation on the stock | Jul. 09 | CF |
| CARMAT : Invest Securities reduces its target price | Jul. 09 | CF |
| Carmat: surrounded by analysts' comments | Jun. 19 | CF |
| Euroland Corporate Starts Carmat at Buy | Jun. 19 | MT |
More press releases
More news
| 1 day | +1.64% | ||
| 1 week | -4.44% | ||
| Current month | -0.89% | ||
| 1 month | -20.60% | ||
| 3 months | -53.80% | ||
| 6 months | -65.39% | ||
| Current year | -83.31% |
1 week
1.09
1.26
1 month
1.011.43
Current year
1.017.72
1 year
1.019.99
3 years
1.0123.60
5 years
1.0136.00
10 years
1.0182.00
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
CEO | Chief Executive Officer | 53 | 2016-08-31 |
| Director of Finance/CFO | - | 2018-12-11 | |
Piet Jansen
CTO | Chief Tech/Sci/R&D Officer | 65 | 2010-12-22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Piat
BRD | Director/Board Member | 53 | - |
| Director/Board Member | 66 | 2017-01-01 | |
Michael Mack
BRD | Director/Board Member | 77 | 2017-04-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.64% | -4.44% | -70.73% | -95.01% | 49.02M | ||
| +0.34% | +0.32% | +31.29% | +58.37% | 149B | ||
| -0.73% | -0.68% | -4.33% | -21.71% | 10.99B | ||
| -1.67% | +4.47% | +0.24% | -46.26% | 8.82B | ||
| -2.21% | -3.36% | +108.81% | +237.72% | 7.49B | ||
| +1.79% | +1.46% | +26.48% | -7.55% | 5.75B | ||
| +0.75% | -.--% | +23.44% | +36.50% | 3.63B | ||
| -0.61% | +2.70% | -3.81% | -63.59% | 2.74B | ||
| -0.31% | +1.79% | -14.38% | -34.83% | 2.24B | ||
| -0.75% | +1.64% | -18.91% | -30.40% | 1.84B | ||
| Average | -0.17% | +0.28% | +7.81% | +3.32% | 19.26B | |
| Weighted average by Cap. | +0.11% | +0.35% | +29.03% | +49.90% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 10.07M 10.59M 9.38M 8.36M 14.9M 897M 16.35M 117M 43.26M 368M 39.79M 38.9M 1.58B | 21.21M 22.29M 19.75M 17.61M 31.36M 1.89B 34.43M 246M 91.07M 774M 83.76M 81.89M 3.33B |
| Net income | -42.22M -44.38M -39.32M -35.05M -62.43M -3.76B -68.54M -489M -181M -1.54B -167M -163M -6.64B | -35.56M -37.38M -33.12M -29.53M -52.59M -3.17B -57.73M -412M -153M -1.3B -140M -137M -5.59B |
| Net Debt | 50.19M 52.76M 46.75M 41.67M 74.22M 4.47B 81.48M 581M 215M 1.83B 198M 194M 7.89B | 91.02M 95.68M 84.79M 75.58M 135M 8.11B 148M 1.05B 391M 3.32B 360M 351M 14.31B |
More financial data
* Estimated data
Employees
162
Calendar
2025-02-11
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-04 | 1.110 € | +0.91% | 33,609 |
| 24-12-03 | 1.100 € | -4.35% | 111,365 |
| 24-12-02 | 1.150 € | +1.95% | 197,591 |
| 24-11-29 | 1.128 € | -0.18% | 125,253 |
| 24-11-28 | 1.130 € | -3.42% | 254,662 |
Real-time Euronext Paris, December 04, 2024 at 04:06 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.100EUR
Average target price
6.320EUR
Spread / Average Target
+474.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALCAR Stock